Great Basin Scientific Inc. (Nasdaq: GBSN) reported sharply higher preliminary first quarter revenue and strong customer acquisition growth. Shares of the molecular diagnostic testing company leaped $2.21 to $4.94.
Great Basin reports strong preliminary results
April 15, 2016 at 14:17 PM EDT
